Senti Biosciences Valuation
| SNTI Stock | USD 3.51 0.11 3.04% |
At this time, the company appears to be undervalued. Senti Biosciences has a current Real Value of $5.02 per share. The regular price of the company is $3.51. Our model measures the value of Senti Biosciences from inspecting the company fundamentals such as Return On Equity of -1.11, current valuation of 41.86 M, and Shares Owned By Insiders of 21.00 % as well as reviewing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Senti Biosciences' price fluctuation is risky at this time. Calculation of the real value of Senti Biosciences is based on 3 months time horizon. Increasing Senti Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Senti Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Senti Stock. However, Senti Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.51 | Real 5.02 | Hype 3.51 | Naive 3.83 |
The intrinsic value of Senti Biosciences' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Senti Biosciences' stock price.
Estimating the potential upside or downside of Senti Biosciences helps investors to forecast how Senti stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Senti Biosciences more accurately as focusing exclusively on Senti Biosciences' fundamentals will not take into account other important factors: Senti Biosciences Total Value Analysis
Senti Biosciences is at this time anticipated to have valuation of 41.86 M with market capitalization of 45.89 M, debt of 33.54 M, and cash on hands of 140.78 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Senti Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
41.86 M | 45.89 M | 33.54 M | 140.78 M |
Senti Biosciences Investor Information
About 21.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.1. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Senti Biosciences recorded a loss per share of 15.59. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 18th of July 2024. Based on the key indicators related to Senti Biosciences' liquidity, profitability, solvency, and operating efficiency, Senti Biosciences is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April.Senti Biosciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Senti Biosciences has an asset utilization ratio of 0.35 percent. This signifies that the Company is making $0.003455 for each dollar of assets. An increasing asset utilization means that Senti Biosciences is more efficient with each dollar of assets it utilizes for everyday operations.Senti Biosciences Ownership Allocation
The market capitalization of Senti Biosciences is $45.89 Million. Senti Biosciences maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.Senti Biosciences Profitability Analysis
The company reported the previous year's revenue of 338 K. Net Loss for the year was (52.79 M) with loss before overhead, payroll, taxes, and interest of (29.78 M).About Senti Biosciences Valuation
An absolute valuation paradigm, as applied to Senti Stock, attempts to find the value of Senti Biosciences based on its fundamental and basic technical indicators. By analyzing Senti Biosciences's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Senti Biosciences's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Senti Biosciences. We calculate exposure to Senti Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Senti Biosciences's related companies.Senti Biosciences, Inc. operates as a preclinical biotechnology company that develops next-generation cell and gene therapies engineered with its gene circuit platform technologies for various diseases. The company was incorporated in 2016 and is headquartered in South San Francisco, California. Senti Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 89 people.
Senti Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 4.6 M |
Complementary Tools for Senti Stock analysis
When running Senti Biosciences' price analysis, check to measure Senti Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senti Biosciences is operating at the current time. Most of Senti Biosciences' value examination focuses on studying past and present price action to predict the probability of Senti Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senti Biosciences' price. Additionally, you may evaluate how the addition of Senti Biosciences to your portfolios can decrease your overall portfolio volatility.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |